Abstract No. 29 Varian Velocity 4.0’s RapidSphere dosimetry assessment in predicting treatment outcomes following Yttrium-90 transarterial radioembolization (TARE) of hepatic tumors

Autor: Ward, C., Wesson, W., Mazurek, J., Kozlowski, I., Werner, G., Dehbozorgi, A., Phadnis, M., Walter, C., Rohr, A., Collins, Z.
Zdroj: In Journal of Vascular and Interventional Radiology June 2022 33(6) Supplement:S14-S14
Databáze: ScienceDirect